Search Results

Return to List
Results 1–8 of 8
Sort By: Relevance | Date | Title
1.

Carrier Screening for Genetic Conditions

Committee Opinion Number 691, March 2017

(Replaces Committee Opinion Number 318, October 2005;
Committee Opinion Number 432, May 2009;
Committee Opinion Number 442, October 2009;
Committee Opinion Number 469, October 2010;
Committee Opinion Number 486, April 2011)

ABSTRACT Carrier screening is a term used to describe genetic testing that is performed on an individual who does not have any overt phenotype for a genetic disorder but may have one variant allele within a genes associated with a diagnosis Information about carrier screening should be provided to...

March 2017

PDF Format
2.

Carrier Screening in the Age of Genomic Medicine

Committee Opinion Number 690, March 2017

ABSTRACT Carrier screening whether targeted or expanded allows individuals to consider their range of reproductive options Ultimately the goal of genetic screening is to provide individuals with meaningful information that they can use to guide pregnancy planning based on their personal values Eth...

March 2017

PDF Format
3.

Cell-free DNA Screening for Fetal Aneuploidy

Committee Opinion Number 640, September 2015

(This Committee Opinion Replaces Committee Opinion Number 545)

ABSTRACT Noninvasive prenatal screening that uses cellfree DNA from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy A number of laboratories have validated different techniques for the use of cellfree DNA as a screening test for fetal aneuploidy ...

September 2015

PDF Format
4.

Comprehensive Sexuality Education

Committee Opinion Number 678, November 2016

ABSTRACT Current sexuality education programs vary widely in the accuracy of content emphasis and effectiveness Data have shown that not all programs are equally effective for all ages races and ethnicities socioeconomic groups and geographic areas Studies have demonstrated that comprehensive sexu...

November 2016

PDF Format
5.

Hereditary Cancer Syndromes and Risk Assessment

Committee Opinion Number 634, June 2015

ABSTRACT A hereditary cancer syndrome is a genetic predisposition to certain types of cancer often with onset at an early age caused by inherited mutations in one or more genes Cases of cancer commonly encountered by obstetriciangynecologists or other obstetricgynecologic providersmdashsuch as bre...

June 2015

PDF Format
6.

Identification and Referral of Maternal Genetic Conditions in Pregnancy

Committee Opinion Number 643, October 2015

ABSTRACT Advances in the understanding of genetic conditions reproductive technologies and improved medical and surgical care have enabled an increasing number of women with genetic conditions to achieve a normal pregnancy outcome However management of certain genetic conditions during pregnancy i...

October 2015

PDF Format
7.

Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology

Committee Opinion Number 682, December 2016

(Replaces Committee Opinion Number 581, December 2013)

ABSTRACT Genetic technology has advanced dramatically in the past few decades and its applications and use in caring for and counseling pregnant women has been transformational in the realm of prenatal diagnosis Two of the newer genetic technologies in the prenatal setting are chromosomal microarr...

December 2016

PDF Format
8.

Newborn Screening and the Role of the Obstetrician-Gynecologist

Committee Opinion Number 616, January 2015

(Replaces Committee Opinion Number 481, March 2011, Reaffirmed 2016)

ABSTRACT Newborn screening is a mandatory statebased public health program that provides all newborns in the United States with presymptomatic testing and necessary followup health care for a variety of medical conditions The goal of this essential public health program is to decrease morbidity an...

January 2015

PDF Format
Advertisement

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998